>
CLINICAL STUDIES GROUPS - SUB GROUPS AND WORKING PARTIES
Clinical Studies Group Sub-Groups Working Party Bladder Cancer Group Penile * (Dr J Barber) Chemotherapy Trials* (Dr B Mead) None Brain Tumour Group Novel agents* (Prof. Mike Brada) Technology Development* (Prof G Cruishank) Imaging*(Dr J Rees) Translational*(Dr S Short) QoL/Palliative Care* None Breast Cancer Group Translational (Prof B Steele) Imaging (Prof L Turnball) None Colorectal Cancer Group Surgery (Dr Dion Morton) Prevention and Screening (Prof Bob Steele) Adjuvant Therapy (Prof David Kerr) Advanced Disease (Prof Tim Maughan) Anal Cancer (Prof Roger James) Rectal cancer (Dr David Sebag Montefiore) None Complementary Therapies Specific Effects (Dr T Leatham) Effectiveness (Prof K Thomas) Delivery (Dr J Filshie) None Consumer Liaison Group TBC None Gynaecological Cancer Group Ovarian (Prof Gordon Rustin) Cervical (Dr Peter Blake Vulval (Dr Tito Lopes) Endometrial (Prof Henry Kitchener) Translational (Dr John Green) Screening and Prevention*(Dr J Burns) None Haematological Oncology Group CLL (P Hillman Prof T Hamblin) Paediatrics (Dr B Gibson/Dr I Hann) Myeloma (Prof T Child/ Dr S Schey ) CML (Prof J Goldman) AML (Prof A Burnett) ALL (Prof A Goldstone) MDS (Dr D Bowen) None Head and Neck Cancer Group Thyroid (Pof Jane Franklyn) None Lung Cancer Group SPECTRE (Dr M Peake) LORD (Prof A Price) Mesothelioma (Dr D Waller) NSCLC Stage IIIB 00 SCLC ED( Prof D Ferry) Translational(Prof J Field) Rare Tumours (Dr S Falk) None Lymphoma Group Low Grade Lymphoma (Prof A Lister) High Grade Lymphoma (Prof D Cunningham) Extra Nodal Lymphoma (Dr B Mead) Hodgkins Disease (Prof J Radford) T Cell Lymphoma (Dr R Pettengell) None Melanoma Group Prevention* (Prof R Mackie) Pathology *(Dr N Kirkham) Non Melanoma* (Dr G Marsden) Translational* (Dr C Ottensmeier) Rare melanomas* (Prof A Dalgleish) None Palliative Care Group HSR (Prof C Todd) Pain (Dr M Fallon) Cachexia(Dr A Wilcox) Palliative Care in Primary Care Setting*(Dr S Murray and Dr S Barclay) None Primary Care Group Biomarkers (Prof D Wellar) Early CRC diagnosis (Prof G Rubin) Follow up (Dr Una Macleod) None To become screening and prevention subgroup Prostate Cancer Group Hormone Refactory Prostate Cancer (HRPC) (Mr N Clarke) High Risk (Dr D Gillatt) Early Diagnosis/stage (Dr C Parker) Brachytherapy & QoL/New technologies (Prof. D Dearnaley) None Psychosocial Oncology Survivorship (Mr Nigel Palmer) Quality of Life (Ms J Brown) Interventions (Dr Peter Harvey) Spirituality (Dr L Jones) None Radiotherapy Group None None Renal Cancer Group None Prognostic Factors (Prof B Hancock) Sarcoma Group Synovial Sarcoma (Dr I Lewis) Follow Up Study (Mr R Grimer) Bone Sarcoma (Dr J Whelan) GIST (Dr M Leahy) EURAMOS 1 working party Testis Cancer Group None None TYA Health Service Research Priorities (Dr M Rogers) Cancer Registry (Dr I Lewis) Survivorship and Late Effects (Dr M Hawkins) None UKCC Study Group ? ? Upper Gastro-Intestinal Cancer Group Hepatobillary (Prof J Garden) Pancreas (Prof J Neoptolemos) Oesophagogastric (Prof D Alderson) Chemo-radiation (Dr T Crosby) NoneSeptember 2006
